Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1SHIRE PLC
03 6Takeda Pharmaceutical
01 1Concentrate For Infusion Solution
02 1Concentrate For Solution For Infusion
03 2Concentrate for infusion solution, solution
04 1INJ
05 1INJECTABLE; IV (INFUSION)
06 1Infusion Concentrate
07 1SOLUTION
01 1Allowed
02 1Approved
03 1Authorized
04 1Originator
05 1Schedule D
06 3Blank
01 2ELAPRASE
02 6Elaprase
01 1Canada
02 2Norway
03 1South Africa
04 1Spain
05 1Sweden
06 1Switzerland
07 1USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Elaprase
Dosage Form : INJ
Dosage Strength : 2mg/ml
Packaging : 3X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : USA
Brand Name : ELAPRASE
Dosage Form : INJECTABLE; IV (INFUSION)
Dosage Strength : 6MG/3ML
Packaging :
Approval Date :
Application Number : 125151
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Elaprase
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 2 mg/ml
Packaging : Vials 1 3ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Elaprase
Dosage Form : Concentrate for infusion solution, solution
Dosage Strength : 2 mg/ml
Packaging : Vials 4 3ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Elaprase
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 08/01/2007
Application Number : 20060105000040
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Elaprase
Dosage Form : Infusion Concentrate
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 20/03/2007
Application Number : 57916
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : ELAPRASE
Dosage Form : SOLUTION
Dosage Strength : 2MG/ML
Packaging : 3ML
Approval Date :
Application Number : 2296314
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Elaprase
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 2007-02-08
Application Number : 06365001
Regulatory Info : Authorized
Registration Country : Spain
